Clene Inc. (CLNN) vs Connect Biopharma Holdings Limited (CNTB)

A side-by-side comparison of Clene Inc. and Connect Biopharma Holdings Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CLNN vs CNTB

growth of $100 · dividends reinvested · last 6y
CLNN -98.5% (-50.6%/yr)CNTB -95.1% (-39.6%/yr)CNTB compounded faster over this window
050100150Start $10020222023202420252026$1$5
CLNN CNTB

CLNN vs CNTB: by the numbers

  • •CNTB is the larger company ($56M vs $49M market cap).
  • •Both run net losses; CLNN's is the smaller (-20059.90% vs -86687.50% net margin).

Metrics side by side

Valuation

MetricCLNNCNTB
P/S ratio249.08N/A
P/B ratioN/A2.10

Profitability

MetricCLNNCNTB
Gross margin78.50%100.00%
Operating margin-11541.50%-90740.62%
Net margin-20059.90%-86687.50%
ROEN/A-132.16%
ROIC-109.13%-136.77%

Growth (annualized)

MetricCLNNCNTB
Revenue CAGR (5Y)-18.30%N/A
Total return CAGR (5Y)-51.16%-47.22%

Frequently asked

How have CLNN and CNTB total returns compared?
Over the past 5 years, CLNN delivered -51.16% and CNTB delivered -47.22% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.